TipRanks
TipRanksTop Financial ExpertsInsidersAndrew Schwab

Andrew Schwab Insider Profile

4 Followers
Andrew Schwab, Director, Ten Percent Owner at Skye Bioscience, holds 981.27K shares in Skye Bioscience (Ticker: SKYE), holds 5.28M shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds 960.38K shares in Enliven Therapeutics (Ticker: ELVN). Most recently, Andrew Schwab Sold ― shares of Skye Bioscience on Sep 24, 2026 for an estimated value of $239.56K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Andrew Schwab

Andrew Schwab
Skye Bioscience (SKYE)
Director, Ten Percent Owner

Ranked #9,577 out of 109,287 Corporate Insiders

Profitable Transactions

82%
9 out of 11 Profitable Transactions

Average Return

+18.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$64M
67.45%
30.21%
2.34%
A breakdown of Andrew Schwab's holdings
See the Top Stocks by Insiders

Insider Roles

Enliven Therapeutics
(ELVN)
Director, Ten Percent Owner
CAMP4 Therapeutics Corporation
(CAMP)
Director
Skye Bioscience
(SKYE)
Director, Ten Percent Owner
Roles that Andrew Schwab holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Skye Bioscience
(SKYE)
Rating:Informative Sell
Date:Aug 22, 2025 - Aug 22, 2026
Return:+91.40%
The most profitable trade made by Andrew Schwab
See the Latest Stocks Traded by Insiders

Andrew Schwab's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SKYE
Skye Bioscience
Sep 24, 2026
Director, Ten Percent Owner
Informative Sell
239.56K
$1.49M
CAMP
CAMP4 Therapeutics Corporation
Aug 31, 2026
Director
Informative Sell
1.62M
$19.26M
~FLXN
Flexion Therapeutics
Feb 20, 2014
―
Uninformative Buy
―
$13.79M
SCPH
scPharmaceuticals
May 28, 2020
―
Informative Buy
5.00M
$21.72M
FVAM
5:01 Acquisition Corp Class A
Nov 12, 2020
―
Uninformative Buy
51.26K
$3.65M
PEARQ
Pear Therapeutics
Dec 07, 2021
―
Uninformative Buy
2.00M
$204.95K
ELVN
Enliven Therapeutics
Feb 27, 2023
Director, Ten Percent Owner
Uninformative Buy
―
$43.01M
List of latest transactions for each holding click on a transaction to see Andrew Schwab's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Andrew Schwab insider profile FAQ

What is the percentage of profitable transactions made by Andrew Schwab?
The percentage of profitable transactions made by Andrew Schwab is 82%.
    What is the average return per transaction made by Andrew Schwab?
    The average return per transaction made by Andrew Schwab is 18.40%.
      What stocks does Andrew Schwab hold?
      Andrew Schwab holds: SKYE, CAMP, ~FLXN, SCPH, FVAM, PEARQ, ELVN stocks.
        What was Andrew Schwab’s latest transaction?
        Andrew Schwab latest transaction was an Informative Sell of $239.56K.
          What was Andrew Schwab's most profitable transaction?
          Andrew Schwab’s most profitable transaction was an Informative Sell of SKYE stock on August 22, 2025. The return on the trade was 91.40%.
            What is Andrew Schwab's role in Skye Bioscience?
            Andrew Schwab's role in Skye Bioscience is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.